FDA approves $475000 CAR-T therapy – HealthLeaders Media
|
FDA approves $475000 CAR–T therapy
HealthLeaders Media The Food and Drug Administration (FDA) approved the first gene therapy released in the U.S., Kymriah, also known as chimeric antigen receptor T–cell (CAR-T) therapy. The $475,000 treatment will be outcomes-based; patients will not be charged by the … |
